Literature DB >> 22949539

Transthyretin (TTR) cardiac amyloidosis.

Frederick L Ruberg1, John L Berk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22949539      PMCID： PMC3501197          DOI： 10.1161/CIRCULATIONAHA.111.078915

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  117 in total

1.  Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

Authors:  Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Joseph P McConnell; Mark R Litzow; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; William J Hogan; S Vincent Rajkumar; Rafael Fonseca; Philip R Greipp; Thomas E Witzig; John A Lust; Steven R Zeldenrust; Denise S Snow; Susan R Hayman; Christopher G A McGregor; Allan S Jaffe
Journal:  Blood       Date:  2004-03-25       Impact factor: 22.113

2.  Capillary electrophoretic determination of resveratrol in wines.

Authors:  X Gu; L Creasy; A Kester; M Zeece
Journal:  J Agric Food Chem       Date:  1999-08       Impact factor: 5.279

3.  Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.

Authors:  Ana-Paula Barreiros; Felix Post; Maria Hoppe-Lotichius; Reinhold P Linke; Christian F Vahl; Hans-Joachim Schäfers; Peter R Galle; Gerd Otto
Journal:  Liver Transpl       Date:  2010-03       Impact factor: 5.799

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.

Authors:  R Liao; M Jain; P Teller; L H Connors; S Ngoy; M Skinner; R H Falk; C S Apstein
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

7.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

8.  99mTc-aprotinin scintigraphy in amyloidosis.

Authors:  Bente K Schaadt; Helle W Hendel; Peter Gimsing; Viggo Jønsson; Heidi Pedersen; Birger Hesse
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

9.  Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone.

Authors:  R A Kyle; R D Wagoner; K E Holley
Journal:  Arch Intern Med       Date:  1982-08

10.  Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.

Authors:  V W Lee; A G Caldarone; R H Falk; A Rubinow; A S Cohen
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105
View more
  173 in total

1.  Discordant results between biochemical and molecular transthyretin assays: lessons learned from a unique testing algorithm at the Mayo Clinic.

Authors:  Honey V Reddi; Brittany C Thomas; Kurt S Willkomm; Matthew J Ferber; Kandelaria M Rumilla; Kimiyo M Raymond; John F O'Brien; W Edward Highsmith
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

2.  Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.

Authors:  Marios Arvanitis; Clarissa M Koch; Gloria G Chan; Celia Torres-Arancivia; Michael P LaValley; Daniel R Jacobson; John L Berk; Lawreen H Connors; Frederick L Ruberg
Journal:  JAMA Cardiol       Date:  2017-03-01       Impact factor: 14.676

Review 3.  2021 Advocacy Statements for the Role of 99mTc-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis: A Report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China.

Authors:  Yih-Hwen Huang; Yen-Hung Lin; Ruoh-Fang Yen; Charles Jia-Yin Hou; Shan-Ying Wang; Shih-Chuan Tsai; Kung-Chu Ho; Ming-Hsien Lin; Chin-Ho Tsao; Chih-Yung Chang; Jin-Long Huang; Mei-Fang Cheng; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

4.  Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.

Authors:  Andrzej Witkowski; Gary K L Chan; Jennifer C Boatz; Nancy J Li; Ayuka P Inoue; Jaclyn C Wong; Patrick C A van der Wel; Giorgio Cavigiolio
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

Review 5.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

6.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

7.  Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.

Authors:  Jennaire Lewars; Hersh Wazir; Brandon Gordon; Uyi Faluyi; Yousry Girgis
Journal:  Cureus       Date:  2021-04-21

8.  Amyloidosis of the Brain and Heart: Two Sides of the Same Coin?

Authors:  Chris L Schaich; Mathew S Maurer; Neelesh K Nadkarni
Journal:  JACC Heart Fail       Date:  2019-02       Impact factor: 12.035

9.  Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Authors:  Joseph D Schonhoft; Cecilia Monteiro; Lars Plate; Yvonne S Eisele; John M Kelly; Daniel Boland; Christopher G Parker; Benjamin F Cravatt; Sergio Teruya; Stephen Helmke; Mathew Maurer; John Berk; Yoshiki Sekijima; Marta Novais; Teresa Coelho; Evan T Powers; Jeffery W Kelly
Journal:  Sci Transl Med       Date:  2017-09-13       Impact factor: 17.956

Review 10.  Novel drugs targeting transthyretin amyloidosis.

Authors:  Mazen Hanna
Journal:  Curr Heart Fail Rep       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.